{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:32:36Z","timestamp":1794526356367,"version":"4.9.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>An imbalance in the expression of vascular endothelial growth factor (VEGF) and its receptor (VEGF-R) during pregnancy plays an important role in the pathogenesis of gestational diabetes mellitus (GDM) and eclampsia. VEGF and its receptors change during the regulation of blood vessels as a result of risk factors such as familial genetics. These modifications include loss of original balance of serological indicators, upregulation or downregulation of growth factor indicators, and changes in the placenta, kidney, liver and other organs to varying degrees of damage. This has an impact on both the pregnant woman's and the fetus's health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>This paper summarizes the mechanisms of unbalanced VEGF and receptor expression based on data from relevant literature on GDM and eclampsia. An Imbalance in VEGF and its binding receptor is often associated with the occurrence of multiple pregnancy disorders. In recent years, researchers have focused on the potential role of VEGF and its receptors in the development of GDM and eclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This paper summarizes the different VEGF subtypes and their binding receptors, as well as mechanisms that cause GDM and eclampsia, in order to provide valuable data to inform monitoring, diagnosis, and prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-022-03603-4","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T16:37:13Z","timestamp":1662395833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Vascular endothelial growth factor and its receptors regulation in gestational diabetes mellitus and eclampsia"],"prefix":"10.1186","volume":"20","author":[{"given":"Alayi","family":"Bolatai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-3231","authenticated-orcid":false,"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"3603_CR1","first-page":"455","volume":"59","author":"CS Melincovici","year":"2018","unstructured":"Melincovici CS, Bo\u015fca AB, \u015eu\u015fman S, M\u0103rginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59:455\u201367.","journal-title":"Rom J Morphol Embryol"},{"key":"3603_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669\u201376.","journal-title":"Nat Med"},{"key":"3603_CR3","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.3390\/ijms22147760","volume":"22","author":"GA Secker","year":"2021","unstructured":"Secker GA, Harvey NL. Regulation of VEGFR signalling in lymphatic vascular development and disease: an update. Int J Mol Sci. 2021;22:7760.","journal-title":"Int J Mol Sci"},{"key":"3603_CR4","first-page":"146","volume":"2014","author":"LF Zhou","year":"2014","unstructured":"Zhou LF, Duan T. Research progress of vascular endothelial growth factor and pregnancy. Prog Mod Obstet Gynecol. 2014;2014:146\u20139.","journal-title":"Prog Mod Obstet Gynecol"},{"key":"3603_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016;17:611\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3603_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41433-021-01750-4","volume":"36","author":"I Chatziralli","year":"2022","unstructured":"Chatziralli I, Touhami S, Cicinelli MV, Agapitou C, Dimitriou E, Theodossiadis G, et al. Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy. Eye (Lond). 2022;36:692\u2013703.","journal-title":"Eye (Lond)"},{"key":"3603_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","volume":"2","author":"JA Nagy","year":"2007","unstructured":"Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol Mech Dis. 2007;2:251\u201375.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"3603_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1042\/CS20040370","volume":"109","author":"H Takahashi","year":"2005","unstructured":"Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci. 2005;109:227\u201341.","journal-title":"Clin Sci"},{"key":"3603_CR9","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1111\/ajt.15331","volume":"19","author":"A-C Salabarria","year":"2019","unstructured":"Salabarria A-C, Braun G, Heykants M, Koch M, Reuten R, Mahabir E, et al. Local VEGF-A blockade modulates the microenvironment of the corneal graft bed. Am J Transpl. 2019;19:2446\u201356.","journal-title":"Am J Transpl"},{"key":"3603_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.616837","volume":"12","author":"M Bourhis","year":"2021","unstructured":"Bourhis M, Palle J, Galy-Fauroux I, Terme M. Direct and indirect modulation of T cells by VEGF-A counteracted by anti-angiogenic treatment. Front Immunol. 2021;12: 616837.","journal-title":"Front Immunol"},{"issue":"01","key":"3603_CR11","first-page":"68","volume":"33","author":"WM Zhao","year":"2017","unstructured":"Zhao WM, Jia GH, Zhou TT, La MJ. Effects of hypoxic environment on VEGF_(165b) gene expression and microvascular density in different tissues of Plateau Zokor. Chin J Appl Physiol. 2017;33(01):68\u201370.","journal-title":"Chin J Appl Physiol."},{"issue":"05","key":"3603_CR12","first-page":"642","volume":"26","author":"XL Tang","year":"2022","unstructured":"Tang XL, Dai Y, Din Q, Li Q, Jiang Q, Li J. Expression and clinical significance of LncRNA H19 and VEGF-B in patients with diabetic retinopathy. Chin Lab Diagn. 2022;26(05):642\u20137.","journal-title":"Chin Lab Diagn."},{"key":"3603_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrendo.2014.114","volume":"10","author":"Y Cao","year":"2014","unstructured":"Cao Y. VEGF-targeted cancer therapeutics\u2014paradoxical effects in endocrine organs. Nat Rev Endocrinol. 2014;10:530\u20139.","journal-title":"Nat Rev Endocrinol"},{"key":"3603_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jb\/mvs136","volume":"153","author":"M Shibuya","year":"2013","unstructured":"Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2013;153:13\u20139.","journal-title":"J Biochem"},{"key":"3603_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/17474124.2016.1207523","volume":"10","author":"E Ahmadian","year":"2016","unstructured":"Ahmadian E, Pennefather PS, Eftekhari A, Heidari R, Eghbal MA. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention. Expert Rev Gastroenterol Hepatol. 2016;10:1279\u201388.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"26","key":"3603_CR16","first-page":"74","volume":"17","author":"Y Yuan","year":"2017","unstructured":"Yuan Y, Zhao K, Lu N. Research progress of VEGF\/VEGFR signaling pathway and related inhibitors. A summary of the latest medical information in the world. 2017;17(26):74\u20135.","journal-title":"A summary of the latest medical information in the world."},{"key":"3603_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131946","volume":"10","author":"C Wittig","year":"2015","unstructured":"Wittig C, Scheuer C, Parakenings J, Menger MD, Laschke MW. Geraniol suppresses angiogenesis by downregulating vascular endothelial growth factor (VEGF)\/VEGFR-2 signaling. PLoS ONE. 2015;10: e0131946.","journal-title":"PLoS ONE"},{"key":"3603_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-01198-4","volume":"20","author":"P Zanjanchi","year":"2022","unstructured":"Zanjanchi P, Asghari SM, Mohabatkar H, Shourian M, Shafiee AM. Conjugation of VEGFR1\/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity. J Nanobiotechnol. 2022;20:1\u201322.","journal-title":"J Nanobiotechnol"},{"key":"3603_CR19","first-page":"1754","volume":"16","author":"DX Zhang","year":"2021","unstructured":"Zhang DX, Yuan NL, He Q, Zhao YH. Research progress on the relationship between vascular endothelial growth factor and pregnancy-related diseases. Chin Med. 2021;16:1754\u20136.","journal-title":"Chin Med"},{"key":"3603_CR20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2174\/0929867327666200207120158","volume":"28","author":"N Karamzad","year":"2021","unstructured":"Karamzad N, Eftekhari A, Ashrafi-Asgarabad A, Sullman MJM, Sahebkar A, Safiri S. Serum hepcidin, the hepcidin\/ferritin ratio and the risk of type 2 diabetes: a systematic review and meta-analysis. Curr Med Chem. 2021;28:1224\u201333.","journal-title":"Curr Med Chem"},{"key":"3603_CR21","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1007\/s11010-021-04137-x","volume":"476","author":"C Ma","year":"2021","unstructured":"Ma C, Liu G, Liu W, Xu W, Li H, Piao S, et al. CXCL1 stimulates decidual angiogenesis via the VEGF-A pathway during the first trimester of pregnancy. Mol Cell Biochem. 2021;476:2989\u201398.","journal-title":"Mol Cell Biochem"},{"key":"3603_CR22","unstructured":"Wu XF, Liu T, Zhang Q. Progress in the mechanism of pro-angiogenic factors on diabetic foot. Med Inform. 2018."},{"key":"3603_CR23","first-page":"868","volume":"26","author":"YY Wang","year":"2020","unstructured":"Wang YY, Zhang JW, Cai YQ. Correlation between vascular endothelial growth factor expression and gene polymorphisms and the risk of gestational diabetes mellitus. Hebei Med. 2020;26:868\u201372.","journal-title":"Hebei Med"},{"key":"3603_CR24","first-page":"1227","volume":"48","author":"XR Sun","year":"2013","unstructured":"Sun XR. The value of Vascular endothelial growth factor in neonatal diabetes. Jiangxi Med. 2013;48:1227\u20139.","journal-title":"Jiangxi Med"},{"key":"3603_CR25","first-page":"1227","volume":"48","author":"XR Sun","year":"2013","unstructured":"Wu FF, Jiang WJ. Trends in the change of Cfp-mRNA, Cff-DNA and VEGF, and SFlt-1 levels in the peripheral blood of pregnant women with gestational diabetes.  Medical J Air Force. 2019;(5):425-8.","journal-title":"Jiangxi Med"},{"issue":"02","key":"3603_CR26","first-page":"188","volume":"24","author":"ZS Wang","year":"2021","unstructured":"Wang ZS, Xie XH, Shen HC. Changes in vascular endothelial growth factor, placental growth factor, and serum soluble epidermal growth factor receptor protein in the placental tissue and maternal serum of pregnant women with preeclampsia. Chin Med J Natl Coal Ind. 2021;24(02):188\u201391.","journal-title":"Chin Med J Natl Coal Ind."},{"key":"3603_CR27","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.2147\/IJGM.S316670","volume":"14","author":"E Al-Ofi","year":"2021","unstructured":"Al-Ofi E, Alrafiah A, Maidi S, Almaghrabi S, Hakami N. Altered expression of angiogenic biomarkers in pregnancy associated with gestational diabetes. Int J Gen Med. 2021;14:3367.","journal-title":"Int J Gen Med"},{"key":"3603_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1570161118666200616144512","volume":"19","author":"S Bedell","year":"2021","unstructured":"Bedell S, Hutson J, de Vrijer B, Eastabrook G. Effects of maternal obesity and gestational diabetes mellitus on the placenta: current knowledge and targets for therapeutic interventions. Curr Vasc Pharmacol. 2021;19:176\u201392.","journal-title":"Curr Vasc Pharmacol"},{"key":"3603_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1042\/bio_2021_117","volume":"43","author":"A Byford","year":"2021","unstructured":"Byford A, Baird-Rayner C, Forbes K. Don\u2019t sugar coat it: the effects of gestational diabetes on the placental vasculature. Biochemist. 2021;43:34\u20139.","journal-title":"Biochemist"},{"key":"3603_CR30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/nu13041303","volume":"13","author":"C Diceglie","year":"2021","unstructured":"Diceglie C, Anelli GM, Martelli C, Serati A, Lo Dico A, Lisso F, et al. Placental antioxidant defenses and autophagy-related genes in maternal obesity and gestational diabetes mellitus. Nutrients. 2021;13:1303.","journal-title":"Nutrients"},{"key":"3603_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105426","volume":"165","author":"A Hosni","year":"2021","unstructured":"Hosni A, Abd El-twab S, Abdul-Hamid M, Prinsen E, AbdElgawad H, Abdel-Moneim A, et al. Cinnamaldehyde mitigates placental vascular dysfunction of gestational diabetes and protects from the associated fetal hypoxia by modulating placental angiogenesis, metabolic activity and oxidative stress. Pharmacol Res. 2021;165: 105426.","journal-title":"Pharmacol Res"},{"key":"3603_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1595576","author":"S Krishnasamy","year":"2019","unstructured":"Krishnasamy S, Ravi V, Rajaraman B, Thulasingam SK, Dhevasena CS, Pathak A, et al. Role of VEGF165b\/VEGFTOTAL ratio in gestational diabetes mellitus. Gynecol Endocrinol. 2019. https:\/\/doi.org\/10.1080\/09513590.2019.1595576.","journal-title":"Gynecol Endocrinol"},{"key":"3603_CR33","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1002\/jcp.24993","volume":"230","author":"SA Sultan","year":"2015","unstructured":"Sultan SA, Liu W, Peng Y, Roberts W, Whitelaw D, Graham AM. The role of maternal gestational diabetes in inducing fetal endothelial dysfunction. J Cell Physiol. 2015;230:2695\u2013705.","journal-title":"J Cell Physiol"},{"key":"3603_CR34","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.3390\/ijms222112048","volume":"22","author":"R Atallah","year":"2021","unstructured":"Atallah R, Gindlhuber J, Platzer W, B\u00e4rnthaler T, Tatzl E, Toller W, et al. SUCNR1 is expressed in human placenta and mediates angiogenesis: significance in gestational diabetes. Int J Mol Sci. 2021;22:12408.","journal-title":"Int J Mol Sci."},{"key":"3603_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.650328","author":"A Alqudah","year":"2021","unstructured":"Alqudah A, Eastwood K-A, Jerotic D, Todd N, Hoch D, McNally R, et al. FKBPL and SIRT-1 are downregulated by diabetes in pregnancy impacting on angiogenesis and endothelial function. Front Endocrinol. 2021. https:\/\/doi.org\/10.3389\/fendo.2021.650328.","journal-title":"Front Endocrinol"},{"issue":"01","key":"3603_CR36","first-page":"81","volume":"21","author":"XL Ma","year":"2020","unstructured":"Ma XL, Li LY. Serum expression of RBP4, Visfatin, and VEGF in pregnant women with gestational diabetes mellitus and its relationship to perinatal outcomes. Chin Clin J Obstet Gynecol. 2020;21(01):81\u20132.","journal-title":"Chin Clin J Obstet Gynecol."},{"key":"3603_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182509","volume":"12","author":"F Troncoso","year":"2017","unstructured":"Troncoso F, Acurio J, Herlitz K, Aguayo C, Bertoglia P, Guzman-Gutierrez E, et al. Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1. PLoS ONE. 2017;12: e0182509.","journal-title":"PLoS ONE"},{"key":"3603_CR38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.placenta.2010.07.003","volume":"31","author":"L Pietro","year":"2010","unstructured":"Pietro L, Daher S, Rudge MVC, de Calderon I MP, Damasceno DC, Sinzato YK, et al. Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women. Placenta. 2010;31:770\u201380.","journal-title":"Placenta"},{"key":"3603_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220650","volume":"14","author":"M Sugimoto","year":"2019","unstructured":"Sugimoto M, Kondo M, Kamimoto Y, Ikeda T, Cutler A, Mariya A, et al. Changes in VEGF-related factors are associated with presence of inflammatory factors in carbohydrate metabolism disorders during pregnancy. PLoS ONE. 2019;14: e0220650.","journal-title":"PLoS ONE"},{"key":"3603_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22686","volume":"33","author":"P Dong","year":"2019","unstructured":"Dong P. Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus. J Clin Lab Anal. 2019;33: e22686.","journal-title":"J Clin Lab Anal"},{"key":"3603_CR41","first-page":"425","volume":"55","author":"Z Yang","year":"2020","unstructured":"Yang Z, Zhang WY. Interpretation of guidelines for the guidelines for diagnosis and treatment of hypertension in pregnancy (2020). Chin J Obstet Gynecol Department. 2020;55:425\u201332.","journal-title":"Chin J Obstet Gynecol Department"},{"key":"3603_CR42","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1080\/14767058.2018.1443066","volume":"32","author":"LE Ali","year":"2019","unstructured":"Ali LE, Salih MM, Elhassan EM, Mohmmed AA, Adam I. Placental growth factor, vascular endothelial growth factor, and hypoxia-inducible factor-1\u03b1 in the placentas of women with pre-eclampsia. J Matern Fetal Neonatal Med. 2019;32:2628\u201332.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3603_CR43","first-page":"70","volume":"30","author":"Y Yu","year":"2020","unstructured":"Yu Y, Lu HY. Correlation study of vascular endothelial growth factor imbalance and complement deposition and pre-eclampsia. Chin J Comp Med. 2020;30:70\u20136.","journal-title":"Chin J Comp Med"},{"key":"3603_CR44","doi-asserted-by":"publisher","DOI":"10.1042\/BST0371237","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Cudmore MJ. Can the biology of VEGF and haem oxygenases help solve pre-eclampsia? Biochem Soc Trans. 2009. https:\/\/doi.org\/10.1042\/BST0371237.","journal-title":"Biochem Soc Trans"},{"key":"3603_CR45","first-page":"77","volume":"23","author":"B Varughese","year":"2010","unstructured":"Varughese B, Bhatla N, Kumar R, Dwivedi SN, Dhingra R. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia. Natl Med J India. 2010;23:77.","journal-title":"Natl Med J India"},{"key":"3603_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cvr\/cvq346","volume":"89","author":"T Cindrova-Davies","year":"2011","unstructured":"Cindrova-Davies T, Sanders DA, Burton GJ, Charnock-Jones DS. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res. 2011;89:671\u20139.","journal-title":"Cardiovasc Res"},{"key":"3603_CR47","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3892\/etm.2020.8707","volume":"20","author":"D Dong","year":"2020","unstructured":"Dong D, Khoong Y, Ko Y, Zhang Y. microRNA-646 inhibits angiogenesis of endothelial progenitor cells in pre-eclamptic pregnancy by targeting the VEGF-A\/HIF-1\u03b1 axis. Exp Ther Med. 2020;20:1879\u201388.","journal-title":"Exp Ther Med"},{"key":"3603_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1868-7083-5-6","volume":"5","author":"DP Sundrani","year":"2013","unstructured":"Sundrani DP, Reddy US, Joshi AA, Mehendale SS, Chavan-Gautam PM, Hardikar AA, et al. Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia. Clin Epigenetics. 2013;5:1\u201311.","journal-title":"Clin Epigenetics"},{"key":"3603_CR49","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20210874","author":"I Witvrouwen","year":"2021","unstructured":"Witvrouwen I, Mannaerts D, Ratajczak J, Boeren E, Faes E, Van Craenenbroeck AH, et al. MicroRNAs targeting VEGF are related to vascular dysfunction in preeclampsia. 2021. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20210874."},{"key":"3603_CR50","unstructured":"Yu S J. Association study of maternal, offspring VEGF-A gene polymorphism and pre-eclampsia. PhD Thesis. Huazhong University of Science and Technology; 2019."},{"key":"3603_CR51","first-page":"41","volume":"14","author":"R Niktalab","year":"2020","unstructured":"Niktalab R, Piravar Z, Behzadi R. Different polymorphisms of vascular endothelial growth factor gene in patients with pre-eclampsia among the Iranian women population. Int J Fertil Steril. 2020;14:41.","journal-title":"Int J Fertil Steril"},{"key":"3603_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/CS20080270","volume":"116","author":"VL Bills","year":"2009","unstructured":"Bills VL, Varet J, Millar A, Harper SJ, Soothill PW, Bates DO. Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia. Clin Sci. 2009;116:265\u201372.","journal-title":"Clin Sci"},{"key":"3603_CR53","first-page":"601","volume":"54","author":"QQ Xiang","year":"2019","unstructured":"Xiang QQ, Yang Z, Huai J, Wang GJ. Effect of pravastatin on the expression of sFlt-1, PlGF, and VEGF in different pre-eclampsia-like mouse models. Chin J Obstet Gynecol Department. 2019;54:601\u20137.","journal-title":"Chin J Obstet Gynecol Department"},{"key":"3603_CR54","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/jmv.26631","volume":"93","author":"N Yazihan","year":"2021","unstructured":"Yazihan N, Tanacan A, Erol SA, Anuk AT, Sinaci S, Biriken D, et al. Comparison of VEGF-A values between pregnant women with COVID-19 and healthy pregnancies and its association with composite adverse outcomes. J Med Virol. 2021;93:2204\u20139.","journal-title":"J Med Virol"},{"key":"3603_CR55","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1021\/acschemneuro.0c00294","volume":"11","author":"X-X Yin","year":"2020","unstructured":"Yin X-X, Zheng X-R, Peng W, Wu M-L, Mao X-Y. Vascular endothelial growth factor (VEGF) as a vital target for brain inflammation during the COVID-19 outbreak. ACS Chem Neurosci. 2020;11:1704\u20135.","journal-title":"ACS Chem Neurosci"},{"key":"3603_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03079-y","volume":"24","author":"Y Kong","year":"2020","unstructured":"Kong Y, Han J, Wu X, Zeng H, Liu J, Zhang H. VEGF-D: a novel biomarker for detection of COVID-19 progression. Crit Care. 2020;24:1\u20134.","journal-title":"Crit Care"},{"issue":"18","key":"3603_CR57","first-page":"1844","volume":"16","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Lin M, Wang XM. Serum Lipocalin-2, sFlt-1, and PIGF levels and their clinical significance in patients with gestational diabetes mellitus and preeclampsia. J Clin Exp Med. 2017;16(18):1844\u20137.","journal-title":"J Clin Exp Med."},{"issue":"02","key":"3603_CR58","first-page":"213","volume":"31","author":"YL Mao","year":"2021","unstructured":"Mao YL, Li XM, Huang WZ, Mao LL. Correlation studies of soluble vascular endothelial growth factor receptor-1, brain-sodium atridium peptide, and serum nitric oxide levels with maternal preeclampsia conditions. Chin J Health Insp. 2021;31(02):213\u20135.","journal-title":"Chin J Health Insp."},{"issue":"07","key":"3603_CR59","first-page":"1030","volume":"30","author":"L Yang","year":"2015","unstructured":"Yang LP, Hou JD, Duan AH, Shen ZW. Association of the expression of placental growth factor and nitric oxide and early-onset preeclampsia. Mater Child Health Care China. 2015;30(07):1030\u20132.","journal-title":"Mater Child Health Care China."},{"key":"3603_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1570161114666160222115158","volume":"14","author":"A Leiva","year":"2016","unstructured":"Leiva A, Fuenzalida B, Barros E, Sobrevia B, Salsoso R, S\u00e1ez T, et al. Nitric oxide is a central common metabolite in vascular dysfunction associated with diseases of human pregnancy. Curr Vasc Pharmacol. 2016;14:237\u201359.","journal-title":"Curr Vasc Pharmacol"},{"key":"3603_CR61","doi-asserted-by":"publisher","first-page":"14606","DOI":"10.3390\/ijms131114606","volume":"13","author":"L-T Huang","year":"2012","unstructured":"Huang L-T, Hsieh C-S, Chang K-A, Tain Y-L. Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. Int J Mol Sci. 2012;13:14606\u201322.","journal-title":"Int J Mol Sci"},{"key":"3603_CR62","first-page":"1014","volume":"54","author":"BS Wang","year":"2019","unstructured":"Wang BS, Zhou QM, Sheng WW, Wei MT, Yang N, Li YM. Investigation and analysis of the risk factors of gestational diabetes mellitus and pregnancy outcomes in China. Chin Med J. 2019;54:1014\u20139.","journal-title":"Chin Med J"},{"key":"3603_CR63","first-page":"5","volume":"9","author":"HX Yang","year":"2005","unstructured":"Yang HX, Zhang MH, Sun WJ, Dong Y. Related factors of preeclampsia in pregnant women with abnormal glucose metabolism during pregnancy. Chin J Obstet Gynecol Dept. 2005;9:5\u20138.","journal-title":"Chin J Obstet Gynecol Department."},{"key":"3603_CR64","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/jbm.b.34809","volume":"109","author":"F Taati Yengejeh","year":"2021","unstructured":"Taati Yengejeh F, Shabani Shayeh J, Rahmandoust M, Fatemi F, Arjmand S. A highly-sensitive vascular endothelial growth factor-A(165) immunosensor, as a tool for early detection of cancer. J Biomed Mater Res B Appl Biomater. 2021;109:1505\u201311.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"3603_CR65","doi-asserted-by":"publisher","unstructured":"Liu XY, Fu H, Qin Z, Li X, Pan Y, Xu H, Song P, et al. A paper-based all-in-one origami nanobiosensor for point-of- care diagnosis of cardiovascular diseases.\u00a0https:\/\/doi.org\/10.2139\/ssrn.4060674.","DOI":"10.2139\/ssrn.4060674"},{"key":"3603_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","volume":"322","author":"L Duley","year":"2001","unstructured":"Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ. 2001;322:329\u201333.","journal-title":"BMJ"},{"key":"3603_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1055\/s-0036-1571318","volume":"33","author":"MG Leon","year":"2016","unstructured":"Leon MG, Moussa HN, Longo M, Pedroza C, Haidar ZA, Mendez-Figueroa H, et al. Rate of gestational diabetes mellitus and pregnancy outcomes in patients with chronic hypertension. Am J Perinatol. 2016;33:745\u201350.","journal-title":"Am J Perinatol"},{"key":"3603_CR68","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1042\/CS20080562","volume":"116","author":"WB Grant","year":"2009","unstructured":"Grant WB. Role of vitamin D in up-regulating VEGF and reducing the risk of pre-eclampsia. Clin Sci. 2009;116:871\u2013871.","journal-title":"Clin Sci"},{"key":"3603_CR69","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/jog.13186","volume":"43","author":"J Song","year":"2017","unstructured":"Song J, Li Y, An R. Vitamin D restores angiogenic balance and decreases tumor necrosis factor-\u03b1 in a rat model of pre-eclampsia. J Obstet Gynaecol Res. 2017;43:42\u20139.","journal-title":"J Obstet Gynaecol Res"},{"key":"3603_CR70","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/ddr.21596","volume":"80","author":"L Zheng","year":"2019","unstructured":"Zheng L, Huang J, Su Y, Wang F, Kong H, Xin H. Vitexin ameliorates preeclampsia phenotypes by inhibiting TFPI-2 and HIF-1\u03b1\/VEGF in al-NAME induced rat model. Drug Dev Res. 2019;80:1120\u20137.","journal-title":"Drug Dev Res"},{"key":"3603_CR71","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.placenta.2011.06.025","volume":"32","author":"BJ Krause","year":"2011","unstructured":"Krause BJ, Hanson MA, Casanello P. Role of nitric oxide in placental vascular development and function. Placenta. 2011;32:797\u2013805.","journal-title":"Placenta"},{"key":"3603_CR72","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbadis.2017.11.010","volume":"1864","author":"T S\u00e1ez","year":"2018","unstructured":"S\u00e1ez T, Salsoso R, Leiva A, Toledo F, de Vos P, Faas M, et al. Human umbilical vein endothelium-derived exosomes play a role in foetoplacental endothelial dysfunction in gestational diabetes mellitus. Biochim Biophys Acta Mol Basis Dis. 2018;1864:499\u2013508.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3603_CR73","unstructured":"Li Y. Study on the correlation of serum adiponectin, nitric oxide and C-peptide in patients with hypertension during pregnancy. 2008."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03603-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03603-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T05:04:07Z","timestamp":1668747847000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03603-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3603"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03603-4","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"400"}}